‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples
- 30 June 2000
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 36 (10), 1248-1257
- https://doi.org/10.1016/s0959-8049(00)00092-7
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Hemmung der Tumorneoangiogenese und Induktion von Apoptose als Eigenschaften von Docetaxel (Taxotere®)Mund-,Kiefer- und Gesichtschirurgie, 1999
- Comparative Expression of Novel Vascular Endothelial Growth Factor/Vascular Permeability Factor Transcripts in Skin, Papillomas, and Carcinomas of v-Ha-rasTg.AC Transgenic Mice and FVB/N MiceBiochemical and Biophysical Research Communications, 1998
- The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activationCarcinogenesis: Integrative Cancer Research, 1997
- Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cellsCancer Letters, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3Cell, 1993
- Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanismEuropean Journal of Cancer and Clinical Oncology, 1991
- Programmed cell death: Apoptosis and oncogenesisCell, 1991
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989